Abstract
The two primary classes of anti-thrombotic drugs are antiplatelet and anticoagulant agents. Seeking an optimal balance between reducing the risk of thrombosis and minimizing the risk of periprocedural bleeding for cardiac surgical patients is imperative. Widespread introduction of new anticoagulant agents have made achieving this balance more challenging. This chapter will examine preoperative management of both antiplatelet and anticoagulant agents, including the decision to continue or hold therapy leading up to surgery; estimating thromboembolic risk; bridging for elective cardiac surgery patients; and estimating bleeding risk. It also examines the management of perioperative bleeding due to antithrombotic therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Douketis J, Spyropoulos A, Spencer F, Mayr M, Jaffer A, Eckman M, et al. Perioperative management of antithrombotic therapy. Chest. 2012;141(2):e326S–50S.
Spyropoulos A, Douketis J. How I treat anticoagulated patients undergoing an elective procedure or surgery. Blood. 2012;120(15):2954–62.
Baron T, Kamath P, McBane R. Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med. 2013;368(22):2113–24.
Leitch J, van Vlymen J. Managing the perioperative patient on direct oral anticoagulants. Can J Anaesth. 2017;64(6):656–72.
Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev. 2012;14(3):CD005011. https://doi.org/10.1002/14651858.CD005011.pub4.
2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011 Mar;91(3):944–82. https://doi.org/10.1016/j.athoracsur.2010.11.078
Dale B, Chan N, Eikelboom J. Laboratory measurement of the direct oral anticoagulants. Br J Haematol. 2015;172(3):315–36.
Nishimura R, Otto C, Bonow R, Carabello B, Erwin J, Guyton R, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary. J Am Coll Cardiol. 2014;63(22):2438–88.
Nishimura R, Otto C, Bonow R, Carabello B, Erwin J, Fleisher L, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease. J Am Coll Cardiol. 2017;70(2):252–89.
Dubois V, Dincq A, Douxfils J, Ickx B, Samama C, Dogné J, et al. Perioperative management of patients on direct oral anticoagulants. Thromb J. 2017;15(1):15.
CHADS2 Score
Gage B. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation. 2004;110(16):2287–92.
CHEST 2012 Guidelines
Guyatt G, Akl E, Crowther M, Gutterman D, Schuünemann H. Executive summary. Chest. 2012;141(2):7S–47S.
CHADS2-VASC SCORE
Lip G, Nieuwlaat R, Pisters R, Lane D, Crijns H. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach. Chest. 2010;137(2):263–72.
Thrombosis Canada
Clinical Guides. Thrombosis Canada [Internet]. Thrombosiscanada.ca. 2017 [cited 12 September 2017]. Available from: http://thrombosiscanada.ca/clinicalguides/#
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Bhuptani, P., Suen, A.T.H., Mazer, C.D. (2021). Perioperative Management of Cardiac Surgical Patients Receiving Antithrombotic Agents. In: Cheng, D.C., Martin, J., David, T. (eds) Evidence-Based Practice in Perioperative Cardiac Anesthesia and Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-47887-2_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-47887-2_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-47886-5
Online ISBN: 978-3-030-47887-2
eBook Packages: MedicineMedicine (R0)